These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 6289461

  • 1. Beta-subunit hCG and the control of trophoblastic disease.
    Zárate A, MacGregor C.
    Semin Oncol; 1982 Jun; 9(2):187-90. PubMed ID: 6289461
    [No Abstract] [Full Text] [Related]

  • 2. Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.
    Dawood MY, Saxena BB, Landesman R.
    Obstet Gynecol; 1977 Aug; 50(2):172-81. PubMed ID: 195242
    [Abstract] [Full Text] [Related]

  • 3. Post-operative follow-up study of trophoblastic tumors using radioimmunoassay for HCG and LH.
    Chen T.
    Acta Obstet Gynaecol Jpn; 1971 Jan; 18(1):13-8. PubMed ID: 4326707
    [No Abstract] [Full Text] [Related]

  • 4. Criteria toward the definition of nonmetastatic gestational trophoblastic disease after hydatidiform mole.
    Kohorn EI.
    Am J Obstet Gynecol; 1982 Feb 15; 142(4):416-9. PubMed ID: 6277194
    [Abstract] [Full Text] [Related]

  • 5. Application of the radioreceptor assay for human chorionic gonadotropin in pregnancy testing and management of trophoblastic disease.
    Boyko WL, Russell HT.
    Obstet Gynecol; 1977 Sep 15; 50(3):324-32. PubMed ID: 197458
    [Abstract] [Full Text] [Related]

  • 6. A radioimmunoassay for pregnancy associated protein, beta 1SP1: levels in pregnancy, trophoblastic and neoplastic disease.
    Elvers LH, Hiemstra G, Lequin RM.
    Horm Res; 1980 Sep 15; 12(5):245-52. PubMed ID: 6249709
    [Abstract] [Full Text] [Related]

  • 7. Gestational trophoblastic neoplasia.
    Hammond CB, Weed JC, Barnard DE, Tyrey L.
    CA Cancer J Clin; 1981 Sep 15; 31(6):322-32. PubMed ID: 6286054
    [Abstract] [Full Text] [Related]

  • 8. Change in human chorionic gonadotropin in gestational trophoblastic disease observed during the course of chemotherapy.
    Huang SC, Hsieh CY, Ouyang PC.
    J Formos Med Assoc; 1991 Jan 15; 90(1):53-8. PubMed ID: 1679110
    [Abstract] [Full Text] [Related]

  • 9. Molecular heterogeneity of human chorionic gonadotropin in serum and urine from patients with trophoblastic tumors.
    Hoermann R, Spoettl G, Grossmann M, Saller B, Mann K.
    Clin Investig; 1993 Nov 15; 71(11):953-60. PubMed ID: 8312691
    [Abstract] [Full Text] [Related]

  • 10. Monitor of chemotherapy in gestational trophoblastic neoplasm by radioimmunoassay of the beta-subunit of human chorionic gonadotropin.
    Jones WB, Lewis JL, Lehr M.
    Am J Obstet Gynecol; 1975 Mar 01; 121(5):669-73. PubMed ID: 46716
    [Abstract] [Full Text] [Related]

  • 11. Affinity to lectin, biological and immunological characteristics of human chorionic gonadotropins from pregnant women and trophoblastic tumour patients.
    Koyama K, Toda K, Kuriyama D, Isojima S.
    Acta Endocrinol (Copenh); 1986 Aug 01; 112(4):579-85. PubMed ID: 3019056
    [Abstract] [Full Text] [Related]

  • 12. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
    Fan C, Goto S, Furuhashi Y, Tomoda Y.
    J Clin Endocrinol Metab; 1987 Feb 01; 64(2):313-8. PubMed ID: 2432080
    [Abstract] [Full Text] [Related]

  • 13. [Characteristics and treatment of choriocarcinoma and related trophoblastic tumors in women].
    Hertz R.
    Geburtshilfe Frauenheilkd; 1968 Sep 01; 28(9):809-23. PubMed ID: 4304185
    [No Abstract] [Full Text] [Related]

  • 14. Endocrinology and treatment of trophoblastic tumours.
    Bagshawe KD.
    J Clin Pathol Suppl (R Coll Pathol); 1976 Sep 01; 10():140-4. PubMed ID: 184116
    [No Abstract] [Full Text] [Related]

  • 15. Criteria of complete remission from trophoblastic neoplasia with the use of human chorionic gonadotropin (HCG) excretion pattern as a parameter.
    Tomoda Y, Asai Y, Arii Y, Kaseki S, Nishi H, Miwa T, Saiki N, Ishizuka N.
    Cancer; 1977 Sep 01; 40(3):1016-25. PubMed ID: 198083
    [Abstract] [Full Text] [Related]

  • 16. Malignant trophoblastic neoplasia. Monitoring of therapy.
    Kolstad P, Hoeg K, Norman N.
    Acta Obstet Gynecol Scand; 1972 Sep 01; 51(3):275-81. PubMed ID: 4342019
    [No Abstract] [Full Text] [Related]

  • 17. Monitoring of trophoblastic neoplasms through radioimmunoassay of the urinary carboxy-terminal fragment of beta-choriogonadotropin (COOH-beta-HCG-RIA).
    Ayala AR, González E, Castorena G, de Jesús Montoya J.
    Arch Invest Med (Mex); 1984 Sep 01; 15(2):139-45. PubMed ID: 6207791
    [No Abstract] [Full Text] [Related]

  • 18. Clinical applications of hCG.
    Bagshawe KD.
    Adv Exp Med Biol; 1984 Sep 01; 176():313-24. PubMed ID: 6093465
    [No Abstract] [Full Text] [Related]

  • 19. [Diagnostic value of determining chorionic gonadotropin and trophoblastic beta 1-glycoprotein in trophoblastic disease].
    Grinevich IuA, Tatarinov IuS, Iugrinova LG, Olefirenko GA, Dotsenko IuS.
    Vopr Onkol; 1981 Sep 01; 27(12):19-23. PubMed ID: 6275607
    [Abstract] [Full Text] [Related]

  • 20. Primary oral etoposide therapy in gestational trophoblastic disease. An update.
    Wong LC, Choo YC, Ma HK.
    Cancer; 1986 Jul 01; 58(1):14-7. PubMed ID: 3011237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.